Italia markets closed

Octopus AIM VCT Ord (OOA.L)

LSE - LSE Prezzo differito. Valuta in GBp (0.01 GBP).
Aggiungi a watchlist
61,500,00 (0,00%)
In data: 02:46PM BST. Mercato aperto.
Schermo intero
Chiusura precedente61,50
Aperto0,00
Denaro0,00 x 0
Lettera63,00 x 0
Min-Max giorno0,00 - 0,00
Intervallo di 52 settimane
Volume0
Media Volume7.631
Capitalizzazione124,929M
Beta (5 anni mensile)N/D
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utili02 mag 2024 - 03 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Purchase of Own Securities and Total Voting Rights

    Octopus AIM VCT plc Purchase of Own Securities and Total Voting Rights Octopus AIM VCT plc (the ‘Company’) announces that on 21 September 2023 the Company purchased for cancellation 284,846 ordinary shares of 1p each at a price of 64.6p per share. Following this transaction, the issued share capital and total voting rights of the Company will be 178,597,268 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are re

  • GlobeNewswire

    Publication of Prospectus

    Octopus AIM VCT plc Publication of Prospectus Octopus AIM VCT plc and Octopus AIM VCT 2 plc (the “Companies”) have today issued a prospectus relating to a proposed offer for subscription for ordinary shares of 1p each in Octopus AIM VCT plc and 0.01p each in Octopus AIM VCT 2 plc (“New Shares”) to raise up to £20 million, in aggregate, with an over allotment of up to a further £10 million, in aggregate (the “Offer”), following the approval of the prospectus from the Financial Conduct Authority.

  • GlobeNewswire

    Portfolio Update

    Octopus AIM VCT plc Portfolio Update The investment portfolio of Octopus AIM VCT plc (the "Company") as at 13 September 2023 is as follows (the valuations being the unaudited valuations, at bid price, as at 31 July 2023): Portfolio companySectorBook cost (£’000)Movement in valuation (£’000)Fair Value(£’000)Ergomed plcPharmaceuticals & Biotechnology1,1766,7257,901Breedon Group plcConstruction & Materials8594,3505,209Hasgrove plc1Unquoted Investment884,4124,500Judges Scientific plcElectronic & Ele